Drug Profile


Alternative Names: Alpha-methyl-p-tyrosine; Metyrosine; ONO-5371

Latest Information Update: 12 Aug 2015

Price : $50

At a glance

  • Originator Valeant Pharmaceuticals International
  • Developer Ono Pharmaceutical
  • Class Amino acids; Antihypertensives; Small molecules
  • Mechanism of Action Enzyme inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Phaeochromocytoma

Most Recent Events

  • 01 Sep 2015 Phase-I/II clinical trials in Phaeochromocytoma (In adolescents, In adults) in Japan (PO) (JapicCTI152999)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top